Cargando...
Erlotinib induced ectropion following papulopustular rash
BACKGROUND: Erlotinib is a targeted anti-cancer drug which acts through the inhibition of epidermal growth factor receptor (EGFR). MAIN OBSERVATIONS: A 79-year-old developed bilateral ectropion after he received erlotinib treatment for lung adenocarcinoma. The ectropion completely resolved with symp...
Gardado en:
| Publicado en: | J Dermatol Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Specjalisci Dermatolodzy
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517803/ https://ncbi.nlm.nih.gov/pubmed/26236413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2015.1203 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|